Literature DB >> 11005560

Influence of multimodality therapy on the cellular immunity of patients with esophageal cancer.

K Mafune1, Y Tanaka.   

Abstract

BACKGROUND: Cancer patients have often been reported to have impaired immune function, and the effect of treatment modalities, such as surgery, irradiation, and chemotherapy, in depressing patients' immunity has also been reported. In this investigation, the effect of treatment on the cellular immunity of esophageal cancer patients was evaluated.
METHODS: Immunological parameters, such as natural killer (NK) activity and lymphocyte subsets in peripheral blood, were measured in 32 esophageal cancer patients on 5 occasions (on the day of admission, 2 days before surgery, and 1 week, 1 month, and 2 months after surgery).
RESULTS: NK activity was greatly impaired shortly after the operation, and the percentages of lymphocytes as a whole, and CD8+, CD16+, and CD57+ lymphocytes were significantly decreased, on the other hand, a postoperative increase in the CD4+/CD8+ ratio was observed. No significant depression of immune function by postoperative irradiation was observed.
CONCLUSIONS: The results of this study suggest that cellular immunity, especially cytotoxicity, shortly after esophagectomy may be greatly impaired by the surgical stress of esophagectomy and an added effect of chemotherapy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11005560     DOI: 10.1007/bf02725341

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  9 in total

1.  Combined influence of adjuvant therapy and interval after surgery on peripheral CD4(+) T lymphocytes in patients with esophageal squamous cell carcinoma.

Authors:  Yang Ling; Lieying Fan; Chunlei Dong; Jing Zhu; Yongping Liu; Yan Ni; Changtai Zhu; Changsong Zhang
Journal:  Exp Ther Med       Date:  2010-01-01       Impact factor: 2.447

2.  Immune responses and prediction of major infection in patients undergoing transhiatal or transthoracic esophagectomy for cancer.

Authors:  Johanna W van Sandick; Suzanne S Gisbertz; Ineke J M ten Berge; Marja A Boermeester; Tineke C T M van der Pouw Kraan; Theo A Out; Hugo Obertop; J Jan B van Lanschot
Journal:  Ann Surg       Date:  2003-01       Impact factor: 12.969

3.  Effects of depression on parameters of cell-mediated immunity in patients with digestive tract cancers.

Authors:  Ke-Jun Nan; Yong-Chang Wei; Fu-Ling Zhou; Chun-Li Li; Chen-Guang Sui; Ling-Yun Hui; Cheng-Ge Gao
Journal:  World J Gastroenterol       Date:  2004-01-15       Impact factor: 5.742

Review 4.  Surgical trauma-induced immunosuppression in cancer: Recent advances and the potential therapies.

Authors:  Fan Tang; Yan Tie; Chongqi Tu; Xiawei Wei
Journal:  Clin Transl Med       Date:  2020-01

5.  Simultaneous disruption of circulating miR-21 and cytotoxic T lymphocytes (CTLs): Prospective diagnostic and prognostic markers for esophageal squamous cell carcinoma (ESCC).

Authors:  Hadiseh Samiei; Faezeh Ajam; Abdolsamad Gharavi; Sara Abdolmaleki; Parviz Kokhaei; Saeed Mohammadi; Ali Memarian
Journal:  J Clin Lab Anal       Date:  2021-11-19       Impact factor: 2.352

Review 6.  Application of Anesthetics in Cancer Patients: Reviewing Current Existing Link With Tumor Recurrence.

Authors:  Xiaotian Liu; Qian Wang
Journal:  Front Oncol       Date:  2022-02-28       Impact factor: 6.244

7.  Immunologic response to tumor ablation with irreversible electroporation.

Authors:  Xiaoxiang Li; Kui Xu; Wei Li; Xiuchun Qiu; Baoan Ma; Qingyu Fan; Zhao Li
Journal:  PLoS One       Date:  2012-11-06       Impact factor: 3.240

8.  Beneficial immune modulatory effects of a specific nutritional combination in a murine model for cancer cachexia.

Authors:  J Faber; P Vos; D Kegler; K van Norren; J M Argilés; A Laviano; J Garssen; A van Helvoort
Journal:  Br J Cancer       Date:  2008-11-18       Impact factor: 7.640

9.  Surgical treatment for colorectal cancer: analysis of the influence of an enhanced recovery programme on long-term oncological outcomes-a study protocol for a prospective, multicentre, observational cohort study.

Authors:  Jose-M Ramirez-Rodriguez; Javier Martinez-Ubieto; Jose-L Muñoz-Rodes; Jose-R Rodriguez-Fraile; Jose-A Garcia-Erce; Javier Blanco-Gonzalez; Emilio Del Valle-Hernandez; Alfredo Abad-Gurumeta; Eugenia Centeno-Robles; Carolina Martinez-Perez; Miguel Leon-Arellano; Estibaliz Echazarreta-Gallego; Manuela Elia-Guedea; Ana Pascual-Bellosta; Elena Miranda-Tauler; Alba Manuel-Vazquez; Enrique Balen-Rivera; David Alvarez-Martinez; Jose Perez-Peña; Ane Abad-Motos; Elisabeth Redondo-Villahoz; Elena Biosta-Perez; Hector Guadalajara-Labajo; Javier Ripollés-Melchor; Cristina Latre-Saso; Elena Cordoba-Diaz de Laspra; Luis Sanchez-Guillen; Mercedes Cabellos-Olivares; Javier Longas-Valien; Sonia Ortega-Lucea; Julia Ocon-Breton; Antonio Arroyo-Sebastian; Damian Garcia-Olmo
Journal:  BMJ Open       Date:  2020-10-27       Impact factor: 2.692

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.